FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Paddock Laboratories Moexipril HCl Tablets 7 Recall

Moexipril HCl Tablets 7

Paddock Laboratories, LLC · Minneapolis, MN

Risk level
Class II
Reported by FDA
Oct 17, 2012
Recall ID
D-007-2013
Check your lot numberHow we source this data

Summary

Paddock Laboratories recalled Moexipril HCl Tablets 7 starting Oct 3, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-007-2013 on Oct 17, 2012. Reason: Paddock Laboratories, LLC are recalling one lot (2012028142) of Moexipril HCl Tablets 7.5mg (expiration 1/2014) because of a non-conformity dissolution failure result found during routine stability testing at the 6 month test interval. Status: Terminated.

Why it was recalled

Paddock Laboratories, LLC are recalling one lot (2012028142) of Moexipril HCl Tablets 7.5mg (expiration 1/2014) because of a non-conformity dissolution failure result found during routine stability testing at the 6 month test interval.

Product description

Moexipril HCl Tablets 7.5mg, 100 tabs, Rx Only, Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0110-01 ,

Lot numbers, UPCs & expiration codes

2012028142 exp. 1/2014

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-007-2013
Classification
Class II
Status
Terminated
Recall initiated
Oct 3, 2012
FDA report date
Oct 17, 2012
Quantity
2267 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Paddock Laboratories, LLC

Original FDA data

Every field from FDA enforcement report D-007-2013, exactly as published.

Show all FDA fields
City
Minneapolis
State
MN
Status
Terminated
Country
United States
Event ID
63354
Address
3940 Quebec Ave N
Code information
2012028142 exp. 1/2014
Postal code
55427-1244
Report date
Oct 17, 2012
Product type
Drugs
Recall number
D-007-2013
Classification
Class II
Recalling firm
Paddock Laboratories, LLC
Product quantity
2267 bottles
Termination date
Nov 12, 2013
Reason for recall
Paddock Laboratories, LLC are recalling one lot (2012028142) of Moexipril HCl Tablets 7.5mg (expiration 1/2014) because of a non-conformity dissolution failure result found during routine stability testing at the 6 month test interval.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Moexipril HCl Tablets 7.5mg, 100 tabs, Rx Only, Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0110-01 ,
Distribution pattern
Nationwide
Recall initiation date
Oct 3, 2012
Initial firm notification
Letter
Center classification date
Oct 9, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-007-2013, published Oct 17, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls